GSK/GSK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Ticker
GSK
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Brentford, United Kingdom
Employees
70,212
Website
www.gsk.com
GSK Metrics
BasicAdvanced
$61B
Market cap
27.67
P/E ratio
$1.38
EPS
0.27
Beta
$0.75
Dividend rate
1.96%
Dividend yield
Price and volume
Market cap
$61B
Beta
0.27
Dividend rate
$0.75
Financial strength
Current ratio
0.867
Quick ratio
0.574
Long term debt to equity
114.566
Total debt to equity
134.341
Dividend payout ratio (TTM)
50.40%
Interest coverage (TTM)
12.93%
Management effectiveness
Return on assets (TTM)
9.32%
Return on equity (TTM)
38.78%
Valuation
Price to earnings (TTM)
27.67
Price to revenue (TTM)
3.98
Price to book
4.43
Price to tangible book (TTM)
-6.96
Price to free cash flow (TTM)
22.93
Dividend yield (TTM)
1.96%
Growth
Revenue change (TTM)
5.69%
Earnings per share change (TTM)
-69.60%
3-year revenue growth
0.63%
3-year earnings per share growth
-5.81%
3-year dividend per share growth
-16.13%
What the Analysts think about GSK
Analyst Ratings
Majority rating from 8 analysts.
GSK Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
£7.4B
-8.56%
Net income
£1B
198.86%
Profit margin
14.20%
227.19%
GSK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.97
$1.28
$0.72
$1.09
-
Expected
$0.87
$1.14
$0.76
$0.91
$0.99
Surprise
11.72%
11.93%
-5.66%
20.11%
-
GSK News
AllArticlesVideos
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
GlobeNewsWire·2 months ago
Apple, Glencore, Sony, Novo Nordisk, Shell, Goldman Sach, GSK, Qualcomm, AMD, Starbucks, Amazon – Markets Defused
Proactive Investors·2 months ago
GSK plc (GSK) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
Jul
11
GSK
Dividend·Payment
$0.376185
Per share
FAQs
What’s the current market cap for GSK stock?
GSK (GSK) has a market cap of $61B as of July 03, 2024.
What is the P/E ratio for GSK stock?
The price to earnings (P/E) ratio for GSK (GSK) stock is 27.67 as of July 03, 2024.
Does GSK stock pay dividends?
Yes, the GSK (GSK) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $0.74855 and the yield is 1.96%. GSK has a payout ratio of 50.4% on a trailing twelve-month basis.
When is the next GSK dividend payment date?
The next GSK (GSK) dividend payment is scheduled for July 11, 2024.
What is the beta indicator for GSK?
GSK (GSK) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell GSK stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.